Analogous to the EGFR signaling blockade, both EGFR and PI3Kα siRNA or inhibitors attenuated cell proliferation induced by SCEL (Fig. 3H), suggesting that SCEL acts as a tumor-promoting factor by activating EGFR-PI3K-Akt signaling. Here, SCEL is linked to neoplasm.